Epidemiology of virus-induced asthma exacerbations: With special reference to the role of human rhinovirus

Frontiers in Microbiology

Volumn 5, Issue MAY, 2014, Pages

  Saraya, Takeshi ^a   Kurai, Daisuke ^a   Ishii, Haruyuki ^a   Ito, Anri ^a   Sasaki, Yoshiko ^b   Niwa, Shoichi ^b   Kiyota, Naoko ^c   Tsukagoshi, Hiroyuki ^b   Kozawa, Kunihisa ^b   Goto, Hajime ^a   Takizawa, Hajime ^a  

^a KYORIN UNIVERSITY   (Japan)

^b GUNMA PREFECTURAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^c Kumamoto Prefectural Institute of Health and Environmental Science   (Japan)

Author keywords

Asthma exacerbation; Epidemiology; Human rhinovirus; Pathophysiology; Treatment

Indexed keywords

ACTIVIN A; AMBROXOL; AMPHIREGULIN; BETA INTERFERON; CORTICOSTEROID; EPIDERMAL GROWTH FACTOR; ERYTHROMYCIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOFLOXACIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MATRIX METALLOPROTEINASE; MUCIN 5AC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMALIZUMAB; PROCATEROL; RANTES; TIOTROPIUM BROMIDE; TULOBUTEROL; VASCULOTROPIN;

AIRWAY REMODELING; ASTHMA; ASYMPTOMATIC INFECTION; CHEMOTAXIS; COLD; COMMUNITY ACQUIRED PNEUMONIA; DISEASE EXACERBATION; EOSINOPHIL; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN RHINOVIRUS; HUMAN RHINOVIRUS A1; HUMAN RHINOVIRUS A16; HYPOXEMIA; INNATE IMMUNITY; LUNG FIBROSIS; LUNG FUNCTION; MUCOCILIARY CLEARANCE; NONHUMAN; PARAINFLUENZA VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHINOVIRUS INFECTION; SMOKING; SORE THROAT; UPREGULATION; VIRAL RESPIRATORY TRACT INFECTION; WHEEZING;

EID: 84904991486     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00226     Document Type: Review

References (104)

1. Andries, K., Dewindt, B., Snoeks, J., Wouters, L., Moereels, H., Lewi, P. J., et al. (1990). Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J. Virol. 64, 1117-1123.
2. Arakawa, M., Okamoto-Nakagawa, R., Toda, S., Tsukagoshi, H., Kobayashi, M., Ryo, A., et al. (2012). Molecular epidemiological study of human rhinovirus species A, B and C from patients with acute respiratory illnesses in Japan. J. Med. Microbiol. 61, 410-419. doi: 10.1099/jmm.0.035006-0.
3. Arruda, E., Pitkaranta, A., Witek, T. J. Jr., Doyle, C. A., and Hayden, F. G. (1997). Frequency and natural history of rhinovirus infections in adults during autumn. J. Clin. Microbiol. 35, 2864-2868.
4. Atmar, R. L., Guy, E., Guntupalli, K. K., Zimmerman, J. L., Bandi, V. D., Baxter, B. D., et al. (1998). Respiratory tract viral infections in inner-city asthmatic adults. Arch. Intern. Med. 158, 2453-2459. doi: 10.1001/archinte.158.22.2453.
5. Bartlett, N. W., Walton, R. P., Edwards, M. R., Aniscenko, J., Caramori, G., Zhu, J., et al. (2008). Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat. Med. 14, 199-204. doi: 10.1038/nm1713.
6. Becker, T. M., Durrani, S. R., Bochkov, Y. A., Devries, M. K., Rajamanickam, V., and Jackson, D. J. (2013). Effect of exogenous interferons on rhinovirus replication and airway inflammatory responses. Ann. Allergy Asthma Immunol. 111, 397-401. doi: 10.1016/j.anai.2013.07.029.
7. Beckham, J. D., Cadena, A., Lin, J., Piedra, P. A., Glezen, W. P., Greenberg, S. B., et al. (2005). Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J. Infect. 50, 322-330. doi: 10.1016/j.jinf.2004.07.011.
8. Bochkov, Y. A., Hanson, K. M., Keles, S., Brockman-Schneider, R. A., Jarjour, N. N., and Gern, J. E. (2010). Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 3, 69-80. doi: 10.1038/mi.2009.109.
9. Burrows, B., Martinez, F. D., Halonen, M., Barbee, R. A., and Cline, M. G. (1989). Association of asthma with serum IgE levels and skin-test reactivity to allergens. N. Engl. J. Med. 320, 271-277. doi: 10.1056/NEJM198902023200502.
10. Cakebread, J. A., Xu, Y., Grainge, C., Kehagia, V., Howarth, P. H., Holgate, S. T., et al. (2011). Exogenous IFN-beta has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus. J. Allergy Clin. Immunol. 127, 1148e9-1154e9. doi: 10.1016/j.jaci.2011.01.023.
11. Cheung, D., Dick, E. C., Timmers, M. C., De Klerk, E. P., Spaan, W. J., and Sterk, P. J. (1995). Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am. J. Respir. Crit. Care Med. 152, 1490-1496. doi: 10.1164/ajrccm.152.5.7582282.
12. Chun, Y. H., Park, J. Y., Lee, H., Kim, H. S., Won, S., Joe, H. J., et al. (2013). Rhinovirus-infected epithelial cells produce more IL-8 and rantes compared with other respiratory viruses. Allergy Asthma Immunol. Res. 5, 216-223. doi: 10.4168/aair.2013.5.4.216.
13. Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A., Bartlett, N. W., et al. (2006). Role of deficient type III interferon-lambda production in asthma exacerbations. Nat. Med. 12, 1023-1026. doi: 10.1038/nm1462.
14. Corne, J. M., Marshall, C., Smith, S., Schreiber, J., Sanderson, G., Holgate, S. T., et al. (2002). Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359, 831-834. doi: 10.1016/S0140-6736(02)07953-9.
15. DeMore, J. P., Weisshaar, E. H., Vrtis, R. F., Swenson, C. A., Evans, M. D., Morin, A., et al. (2009). Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. J. Allergy Clin. Immunol. 124, 245-252. doi: 10.1016/j.jaci.2009.05.030.
16. Dimopoulos, G., Lerikou, M., Tsiodras, S., Chranioti, A., Perros, E., Anagnostopoulou, U., et al. (2012). Viral epidemiology of acute exacerbations of chronic obstructive pulmonary disease. Pulm. Pharmacol. Ther. 25, 12-18. doi: 10.1016/j.pupt.2011.08.004.
17. Durrani, S. R., Montville, D. J., Pratt, A. S., Sahu, S., Devries, M. K., Rajamanickam, V., et al. (2012). Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J. Allergy Clin. Immunol. 130, 489-495. doi: 10.1016/j.jaci.2012.05.023.
18. Dweik, R. A., Boggs, P. B., Erzurum, S. C., Irvin, C. G., Leigh, M. W., Lundberg, J. O., et al. (2011). An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am. J. Respir. Crit. Care Med. 184, 602-615. doi: 10.1164/rccm.9120-11ST.
19. Fashner, J., Ericson, K., and Werner, S. (2012). Treatment of the common cold in children and adults. Am. Fam. Phys. 86, 153-159.
20. Feltis, B. N., Wignarajah, D., Zheng, L., Ward, C., Reid, D., Harding, R., et al. (2006). Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am. J. Respir. Crit. Care Med. 173, 1201-1207. doi: 10.1164/rccm.200507-1105OC.
21. Fraenkel, D. J., Bardin, P. G., Sanderson, G., Lampe, F., Johnston, S. L., and Holgate, S. T. (1995). Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am. J. Respir. Crit. Care Med. 151, 879-886.
22. Fry, A. M., Lu, X., Olsen, S. J., Chittaganpitch, M., Sawatwong, P., Chantra, S., et al. (2011). Human rhinovirus infections in rural Thailand: epidemiological evidence for rhinovirus as both pathogen and bystander. PLoS ONE 6:e17780. doi: 10.1371/journal.pone.0017780.
23. Fujitsuka, A., Tsukagoshi, H., Arakawa, M., Goto-Sugai, K., Ryo, A., Okayama, Y., et al. (2011). A molecular epidemiological study of respiratory viruses detected in Japanese children with acute wheezing illness. BMC Infect. Dis. 11:168. doi: 10.1186/1471-2334-11-168.
24. Gaajetaan, G. R., Geelen, T. H., Vernooy, J. H., Dentener, M. A., Reynaert, N. L., Rohde, G. G., et al. (2013). Interferon-beta induces a long-lasting antiviral state in human respiratory epithelial cells. J. Infect. 66, 163-169. doi: 10.1016/j.jinf.2012.11.008.
25. Grainge, C. L., Lau, L. C., Ward, J. A., Dulay, V., Lahiff, G., Wilson, S., et al. (2011). Effect of bronchoconstriction on airway remodeling in asthma. N. Engl. J. Med. 364, 2006-2015. doi: 10.1056/NEJMoa1014350.
26. Grunberg, K., Sharon, R. F., Sont, J. K., In't Veen, J. C., Van Schadewijk, W. A., De Klerk, E. P., et al. (2001). Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am. J. Respir. Crit. Care Med. 164, 1816-1822.
27. Grunberg, K., Timmers, M. C., De Klerk, E. P., Dick, E. C., and Sterk, P. J. (1999). Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am. J. Respir. Crit. Care Med. 160, 1375-1380. doi: 10.1164/ajrccm.160.4.9810083.
28. Grunstein, M. M., Hakonarson, H., Whelan, R., Yu, Z., Grunstein, J. S., and Chuang, S. (2001). Rhinovirus elicits proasthmatic changes in airway responsiveness independently of viral infection. J. Allergy Clin. Immunol. 108, 997-1004. doi: 10.1067/mai.2001.120276.
29. Gwaltney, J. M. Jr., Hendley, J. O., Simon, G., and Jordan, W. S. Jr. (1967). Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. JAMA 202, 494-500. doi: 10.1001/jama.1967.03130190100014.
30. Hewson, C. A., Haas, J. J., Bartlett, N. W., Message, S. D., Laza-Stanca, V., Kebadze, T., et al. (2010). Rhinovirus induces Muc5ac in a human infection model and in vitro via NF-kappaB and EGFR pathways. Eur. Respir. J. 36, 1425-1435. doi: 10.1183/09031936.00026910.
31. Hsiao, C. J., Cherry, D. K., Beatty, P. C., and Rechtsteiner, E. A. (2010). National ambulatory medical care survey: 2007 summary. Natl. Health Stat. Report 1:32.
32. Huijskens, E. G., Koopmans, M., Palmen, F. M., Van Erkel, A. J., Mulder, P. G., and Rossen, J. W. (2014). The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia. J. Med. Microbiol. 63, 441-452. doi: 10.1099/jmm.0.067108-0.
33. Hutchinson, A. F., Ghimire, A. K., Thompson, M. A., Black, J. F., Brand, C. A., Lowe, A. J., et al. (2007). A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD. Respir. Med. 101, 2472-2481. doi: 10.1016/j.rmed.2007.07.015.
34. Jackson, D. J., and Johnston, S. L. (2010). The role of viruses in acute exacerbations of asthma. J. Allergy Clin. Immunol. 125, 1178-1187. doi: 10.1016/j.jaci.2010.04.021.
35. Jacobs, S. E., Lamson, D. M., St George, K., and Walsh, T. J. (2013). Human rhinoviruses. Clin. Microbiol. Rev. 26, 135-162. doi: 10.1128/CMR.00077-12.
36. Jennings, L. C., Anderson, T. P., Beynon, K. A., Chua, A., Laing, R. T., Werno, A. M., et al. (2008). Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 63, 42-48. doi: 10.1136/thx.2006.075077.
37. Johansson, N., Kalin, M., Tiveljung-Lindell, A., Giske, C. G., and Hedlund, J. (2010). Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin. Infect. Dis. 50, 202-209. doi: 10.1086/648678.
38. Johnstone, J., Majumdar, S. R., Fox, J. D., and Marrie, T. J. (2008). Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest 134, 1141-1148. doi: 10.1378/chest.08-0888.
39. Johnston, S. L., Pattemore, P. K., Sanderson, G., Smith, S., Campbell, M. J., Josephs, L. K., et al. (1996). The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am. J. Respir. Crit. Care Med. 154, 654-660. doi: 10.1164/ajrccm.154.3.8810601.
40. Johnston, S. L., Pattemore, P. K., Sanderson, G., Smith, S., Lampe, F., Josephs, L., et al. (1995). Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310, 1225-1229. doi: 10.1136/bmj.310.6989.1225.
41. Kennedy, J. L., Turner, R. B., Braciale, T., Heymann, P. W., and Borish, L. (2012). Pathogenesis of rhinovirus infection. Curr. Opin. Virol. 2, 287-293. doi: 10.1016/j.coviro.2012.03.008.
42. Kherad, O., Kaiser, L., Bridevaux, P. O., Sarasin, F., Thomas, Y., Janssens, J. P., et al. (2010). Upper-respiratory viral infection, biomarkers, and COPD exacerbations. Chest 138, 896-904. doi: 10.1378/chest.09-2225.
43. King, G. G., Pare, P. D., and Seow, C. Y. (1999). The mechanics of exaggerated airway narrowing in asthma: the role of smooth muscle. Respir. Physiol. 118, 1-13. doi: 10.1016/S0034-5687(99)00076-6.
44. Kiyota, N., Kobayashi, M., Tsukagoshi, H., Ryo, A., Harada, S., Kusaka, T., et al. (2014). Genetic analysis of human rhinovirus species A to C detected in patients with acute respiratory infection in Kumamoto prefecture, Japan 2011-2012. Infect. Genet. Evol. 21, 90-102. doi: 10.1016/j.meegid.2013.10.024.
45. Kiyota, N., Kushibuchi, I., Kobayashi, M., Tsukagoshi, H., Ryo, A., Nishimura, K., et al. (2013). Genetic analysis of the VP4/VP2 coding region in human rhinovirus species C in patients with acute respiratory infection in Japan. J. Med. Microbiol. 62, 610-617. doi: 10.1099/jmm.0.049072-0.
46. Kloepfer, K. M., Demore, J. P., Vrtis, R. F., Swenson, C. A., Gaworski, K. L., Bork, J. A., et al. (2011). Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16. Ann. Allergy Asthma Immunol. 106, 252-257. doi: 10.1016/j.anai.2010.11.021.
47. Ko, F. W., Ip, M., Chan, P. K., Chan, M. C., To, K. W., Ng, S. S., et al. (2007). Viral etiology of acute exacerbations of COPD in Hong Kong. Chest 132, 900-908. doi: 10.1378/chest.07-0530.
48. Kuga, H., Hoshiyama, Y., Kokubu, F., Imai, T., Tokunaga, H., Matsukura, S., et al. (2000). The correlation between the exacerbation of bronchial asthma and picornavirus (human rhino virus) infection in throat gargles by RT-PCR. Arerugi 49, 358-364.
49. Kurai, D., Saraya, T., Ishii, H., and Takizawa, H. (2013a). Virus-induced exacerbations in asthma and COPD. Front. Microbiol. 4:293. doi: 10.3389/fmicb.2013.00293.
50. Kurai, D., Saraya, T., Ishii, H., Wada, H., Tsukagoshi, H., Takizawa, H., et al. (2013b). Respiratory viral infection in admitted adult patients. Respirology 18, 1-81.
51. Leigh, R., Oyelusi, W., Wiehler, S., Koetzler, R., Zaheer, R. S., Newton, R., et al. (2008). Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. J. Allergy Clin. Immunol. 121, 1238e4-1245e4. doi: 10.1016/j.jaci.2008.01.067.
52. Lieberman, D., Lieberman, D., Shimoni, A., Keren-Naus, A., Steinberg, R., and Shemer-Avni, Y. (2009). Identification of respiratory viruses in adults: nasopharyngeal versus oropharyngeal sampling. J. Clin. Microbiol. 47, 3439-3443. doi: 10.1128/JCM.00886-09.
53. Lieberman, D., Shimoni, A., Shemer-Avni, Y., Keren-Naos, A., Shtainberg, R., and Lieberman, D. (2010). Respiratory viruses in adults with community-acquired pneumonia. Chest 138, 811-816. doi: 10.1378/chest.09-2717.
54. Linsuwanon, P., Payungporn, S., Samransamruajkit, R., Posuwan, N., Makkoch, J., Theanboonlers, A., et al. (2009). High prevalence of human rhinovirus C infection in Thai children with acute lower respiratory tract disease. J. Infect. 59, 115-121. doi: 10.1016/j.jinf.2009.05.009.
55. Loens, K., Goossens, H., De Laat, C., Foolen, H., Oudshoorn, P., Pattyn, S., et al. (2006). Detection of rhinoviruses by tissue culture and two independent amplification techniques, nucleic acid sequence-based amplification and reverse transcription-PCR, in children with acute respiratory infections during a winter season. J. Clin. Microbiol. 44, 166-171. doi: 10.1128/JCM.44.1.166-171.2006.
56. Lopez-Souza, N., Favoreto, S., Wong, H., Ward, T., Yagi, S., Schnurr, D., et al. (2009). In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J. Allergy Clin. Immunol. 123, 1384e2-1390e2. doi: 10.1016/j.jaci.2009.03.010.
57. Luchsinger, V., Ruiz, M., Zunino, E., Martinez, M. A., Machado, C., Piedra, P. A., et al. (2013). Community-acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax 68, 1000-1006. doi: 10.1136/thoraxjnl-2013-203551.
58. Makela, M. J., Puhakka, T., Ruuskanen, O., Leinonen, M., Saikku, P., Kimpimaki, M., et al. (1998). Viruses and bacteria in the etiology of the common cold. J. Clin. Microbiol. 36, 539-542.
59. Matsukura, S., Kurokawa, M., Homma, T., Watanabe, S., Suzuki, S., Ieki, K., et al. (2013). Basic research on virus-induced asthma exacerbation: inhibition of inflammatory chemokine expression by fluticasone propionate. Int. Arch. Allergy Immunol. 161(Suppl. 2), 84-92. doi: 10.1159/000350455.
60. McFadden, E. R. Jr., Pichurko, B. M., Bowman, H. F., Ingenito, E., Burns, S., Dowling, N., et al. (1985). Thermal mapping of the airways in humans. J. Appl. Physiol. 58, 564-570.
61. McManus, T. E., Marley, A. M., Baxter, N., Christie, S. N., O'Neill, H. J., Elborn, J. S., et al. (2008). Respiratory viral infection in exacerbations of COPD. Respir. Med. 102, 1575-1580. doi: 10.1016/j.rmed.2008.06.006.
62. Message, S. D., Laza-Stanca, V., Mallia, P., Parker, H. L., Zhu, J., Kebadze, T., et al. (2008). Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc. Natl. Acad. Sci. U.S.A. 105, 13562-13567. doi: 10.1073/pnas.0804181105.
63. Min, J. Y., and Jang, Y. J. (2012). Macrolide therapy in respiratory viral infections. Mediators Inflamm. 2012, 649570. doi: 10.1155/2012/649570.
64. Nagarkar, D. R., Bowman, E. R., Schneider, D., Wang, Q., Shim, J., Zhao, Y., et al. (2010). Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages. J. Immunol. 185, 2525-2535. doi: 10.4049/jimmunol.1000286.
65. Nicholson, K. G., Kent, J., and Ireland, D. C. (1993). Respiratory viruses and exacerbations of asthma in adults. BMJ 307, 982-986. doi: 10.1136/bmj.307.6910.982.
66. Ohta, K., Yamaguchi, M., Akiyama, K., Adachi, M., Ichinose, M., Takahashi, K., et al. (2011). Japanese guideline for adult asthma. Allergol. Int. 60, 115-145. doi: 10.2332/allergolint.11-RAI-0327.
67. Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., et al. (2006). Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am. J. Respir. Crit. Care Med. 173, 1114-1121. doi: 10.1164/rccm.200506-859OC.
68. Perotin, J. M., Dury, S., Renois, F., Deslee, G., Wolak, A., Duval, V., et al. (2013). Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study. J. Med. Virol. 85, 866-873. doi: 10.1002/jmv.23495.
69. Pierangeli, A., Scagnolari, C., Selvaggi, C., Verzaro, S., Spina, M. T., Bresciani, E., et al. (2011). Rhinovirus frequently detected in elderly adults attending an emergency department. J. Med. Virol. 83, 2043-2047. doi: 10.1002/jmv.22205.
70. Pohunek, P., Warner, J. O., Turzikova, J., Kudrmann, J., and Roche, W. R. (2005). Markers of eosinophilic inflammation and tissue re-modelling in children before clinically diagnosed bronchial asthma. Pediatr. Allergy Immunol. 16, 43-51. doi: 10.1111/j.1399-3038.2005.00239.x.
71. Proud, D. (2005). Nitric oxide and the common cold. Curr. Opin. Allergy Clin. Immunol. 5, 37-42. doi: 10.1097/00130832-200502000-00008.
72. Proud, D. (2011). Role of rhinovirus infections in asthma. Asian Pac. J. Allergy Immunol. 29, 201-208.
73. Prussin, C., Griffith, D. T., Boesel, K. M., Lin, H., Foster, B., and Casale, T. B. (2003). Omalizumab treatment downregulates dendritic cell Fcepsilonri expression. J. Allergy Clin. Immunol. 112, 1147-1154. doi: 10.1016/j.jaci.2003.10.003.
74. Reddel, H. K., Taylor, D. R., Bateman, E. D., Boulet, L. P., Boushey, H. A., Busse, W. W., et al. (2009). An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am. J. Respir. Crit. Care Med. 180, 59-99. doi: 10.1164/rccm.200801-060ST.
75. Rohde, G., Wiethege, A., Borg, I., Kauth, M., Bauer, T. T., Gillissen, A., et al. (2003). Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58, 37-42. doi: 10.1136/thorax.58.1.37.
76. Rotbart, H. A., and Hayden, F. G. (2000). Picornavirus infections: a primer for the practitioner. Arch. Fam. Med. 9, 913-920. doi: 10.1001/archfami.9.9.913.
77. Russell, C. D., Griffiths, S. J., and Haas, J. (2014). Interferon lambda genetic polymorphisms and viral infection: the tip of the iceberg? DNA Cell Biol. 33, 60-63. doi: 10.1089/dna.2013.2261.
78. Sampsonas, F., Kaparianos, A., Lykouras, D., Karkoulias, K., and Spiropoulos, K. (2007). DNA sequence variations of metalloproteinases: their role in asthma and Copd. Postgrad. Med. J. 83, 244-250. doi: 10.1136/pgmj.2006.052100.
79. Sanders, S. P., Proud, D., Permutt, S., Siekierski, E. S., Yachechko, R., and Liu, M. C. (2004). Role of nasal nitric oxide in the resolution of experimental rhinovirus infection. J. Allergy Clin. Immunol. 113, 697-702. doi: 10.1016/j.jaci.2004.01.755.
80. Sears, M. R., Burrows, B., Flannery, E. M., Herbison, G. P., Hewitt, C. J., and Holdaway, M. D. (1991). Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N. Engl. J. Med. 325, 1067-1071. doi: 10.1056/NEJM199110103251504.
81. Seemungal, T., Harper-Owen, R., Bhowmik, A., Moric, I., Sanderson, G., Message, S., et al. (2001). Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164, 1618-1623. doi: 10.1164/ajrccm.164.9.2105011.
82. Simcock, D. E., Kanabar, V., Clarke, G. W., O'Connor, B. J., Lee, T. H., and Hirst, S. J. (2007). Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. Am. J. Respir. Crit. Care Med. 176, 146-153. doi: 10.1164/rccm.200701-042OC.
83. Simmonds, P., McIntyre, C., Savolainen-Kopra, C., Tapparel, C., MacKay, I. M., and Hovi, T. (2010). Proposals for the classification of human rhinovirus species C into genotypically assigned types. J. Gen. Virol. 91, 2409-2419. doi: 10.1099/vir.0.023994-0.
84. Smuts, H. E., Workman, L. J., and Zar, H. J. (2011). Human rhinovirus infection in young African children with acute wheezing. BMC Infect. Dis. 11:65. doi: 10.1186/1471-2334-11-65.
85. Suzuki, T., Yamaya, M., Sekizawa, K., Hosoda, M., Yamada, N., Ishizuka, S., et al. (2002). Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells. Am. J. Respir. Crit. Care Med. 165, 1113-1118. doi: 10.1164/ajrccm.165.8.2103094.
86. Sykes, A., MacIntyre, J., Edwards, M. R., Del Rosario, A., Haas, J., Gielen, V., et al. (2014). Rhinovirus-induced interferon production is not deficient in well controlled asthma. Thorax 69, 240-246. doi: 10.1136/thoraxjnl-2012-202909.
87. Takahashi, K., Suzuki, M., Minh Le, N., Anh, N. H., Huong, L. T., Son, T. V., et al. (2013). The incidence and aetiology of hospitalised community-acquired pneumonia among Vietnamese adults: a prospective surveillance in Central Vietnam. BMC Infect. Dis. 13:296. doi: 10.1186/1471-2334-13-296.
88. Takizawa, H., Desaki, M., Ohtoshi, T., Kikutani, T., Okazaki, H., Sato, M., et al. (1995). Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action. Biochem. Biophys. Res. Commun. 210, 781-786. doi: 10.1006/bbrc.1995.1727.
89. Tan, W. C., Xiang, X., Qiu, D., Ng, T. P., Lam, S. F., and Hegele, R. G. (2003). Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am. J. Med. 115, 272-277. doi: 10.1016/S0002-9343(03)00353-X.
90. Tsukagoshi, H., Ishioka, T., Noda, M., Kozawa, K., and Kimura, H. (2013). Molecular epidemiology of respiratory viruses in virus-induced asthma. Front. Microbiol. 4:278. doi: 10.3389/fmicb.2013.00278.
91. Turner, R. B., and Couch, R. B. (2007). "Rhinovirus," in Fields Virology, 5th edn, eds D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (Philadelphia: Lippincott Williams and Wilkins), 895-909.
92. Tyrrell, D. A., Cohen, S., and Schlarb, J. E. (1993). Signs and symptoms in common colds. Epidemiol. Infect. 111, 143-156. doi: 10.1017/S0950268800056764.
93. van Gageldonk-Lafeber, A. B., Heijnen, M. L., Bartelds, A. I., Peters, M. F., Van Der Plas, S. M., and Wilbrink, B. (2005). A case-control study of acute respiratory tract infection in general practice patients in The Netherlands. Clin. Infect. Dis. 41, 490-497. doi: 10.1086/431982.
94. Wark, P. A., Johnston, S. L., Bucchieri, F., Powell, R., Puddicombe, S., Laza-Stanca, V., et al. (2005). Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 201, 937-947. doi: 10.1084/jem.20041901.
95. Wark, P. A., Johnston, S. L., Moric, I., Simpson, J. L., Hensley, M. J., and Gibson, P. G. (2002). Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur. Respir. J. 19, 68-75. doi: 10.1183/09031936.02.00226302.
96. Watanabe, A., Carraro, E., Kamikawa, J., Leal, E., Granato, C., and Bellei, N. (2010). Rhinovirus species and their clinical presentation among different risk groups of non-hospitalized patients. J. Med. Virol. 82, 2110-2115. doi: 10.1002/jmv.21914.
97. Wootton, S. C., Kim, D. S., Kondoh, Y., Chen, E., Lee, J. S., Song, J. W., et al. (2011). Viral infection in acute exacerbation of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 183, 1698-1702. doi: 10.1164/rccm.201010-1752OC.
98. Yamaya, M. (2012). Virus infection-induced bronchial asthma exacerbation. Pulm. Med. 2012, 834826. doi: 10.1155/2012/834826.
99. Yamaya, M., Nishimura, H., Hatachi, Y., Yasuda, H., Deng, X., Sasaki, T., et al. (2012a). Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells. Eur. Respir. J. 40, 122-132. doi: 10.1183/09031936.00065111.
100. Yamaya, M., Nishimura, H., Hatachi, Y., Yasuda, H., Deng, X., Sasaki, T., et al. (2012b). Levofloxacin inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Antimicrob. Agents Chemother. 56, 4052-4061. doi: 10.1128/AAC.00259-12.
101. Yamaya, M., Nishimura, H., Hatachi, Y., Yoshida, M., Fujiwara, H., Asada, M., et al. (2011). Procaterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Eur. J. Pharmacol. 650, 431-444. doi: 10.1016/j.ejphar.2010.09.056.
102. Yamaya, M., Nishimura, H., Nadine, L., Kubo, H., and Ryoichi, N. (2013). Tulobuterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Physiol. Rep. 1, e00041. doi: 10.1002/phy2.41.
103. Yamaya, M., Nishimura, H., Nadine, L. K., Ota, C., Kubo, H., and Nagatomi, R. (2014). Ambroxol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Arch. Pharm. Res. 37, 520-529. doi: 10.1007/s12272-013-0210-7.
104. Zambrano, J. C., Carper, H. T., Rakes, G. P., Patrie, J., Murphy, D. D., Platts-Mills, T. A., et al. (2003). Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE. J. Allergy Clin. Immunol. 111, 1008-1016. doi: 10.1067/mai.2003.1396.